```html

Löffler Syndrome (Simple Pulmonary Eosinophilia)

Overview

Löffler syndrome, also called **simple pulmonary eosinophilia**, is an acute, transient lung disease characterized by the migration of eosinophils (a type of white‑blood cell) into the lungs and sometimes into the bloodstream. The condition is most often caused by a temporary infection with parasites that invade the respiratory tract, such as Ascaris lumbricoides, Strongyloides stercoralis, or certain filarial worms. The syndrome was first described by the Austrian physician Wilhelm Löffler in 1932.

Who it affects: It occurs worldwide but is most common in regions where soil‑transmitted helminths are endemic (sub‑Saharan Africa, Southeast Asia, parts of Latin America, and rural areas of the United States with poor sanitation). Children and young adults are most frequently affected because they have higher rates of exposure to contaminated soil or untreated water.

Prevalence: Exact global incidence is unclear because many cases resolve spontaneously and are never formally diagnosed. Estimates from epidemiologic surveys suggest that 1–5 % of people living in high‑risk tropical areas develop transient eosinophilic lung infiltrates during a parasitic infection cycle; symptomatic Löffler syndrome represents a fraction of those cases (CDC, WHO).

Symptoms

The clinical picture is usually mild, but the following symptoms may appear alone or in combination, typically 1–2 weeks after exposure to the causative parasite.

• Dry, non‑productive cough – the most common respiratory complaint.
• Wheezing or shortness of breath (dyspnea) – may be mistaken for asthma.
• Fever – low‑grade (≤38 °C) in 30–40 % of patients.
• Chest discomfort or pleuritic pain – sharp pain that worsens with deep breathing.
• Fatigue and malaise – generalized feeling of being unwell.
• Peripheral eosinophilia – blood eosinophil count >500 cells/µL (often >1500 cells/µL).
• Night sweats – occasional but reported in some series.
• Gastrointestinal symptoms – mild abdominal cramping or diarrhea may accompany infection with certain helminths.

Symptoms usually peak within 2–3 weeks and resolve spontaneously in 4–6 weeks in most healthy individuals.

Causes and Risk Factors

Primary Causes

1. Soil‑transmitted helminths – Ascaris lumbricoides (roundworm) is the classic cause; larvae migrate through the lungs during their life cycle.
2. Strongyloides stercoralis – Can cause chronic eosinophilic lung disease, especially in immunocompromised hosts.
3. Filarial parasites – Loa loa and other filariae have been implicated in rare case reports.
4. Other parasites – Toxocara canis, Anisakis, and certain trematodes can produce similar eosinophilic infiltrates.
5. Allergic reactions or drug hypersensitivity – Rarely, certain medications (e.g., antibiotics, NSAIDs) cause pulmonary eosinophilia mimicking Löffler syndrome.

Risk Factors

• Living or traveling to areas with poor sanitation where helminth eggs contaminate soil or water.
• Walking barefoot or eating unwashed raw vegetables.
• Children – higher likelihood of accidental ingestion of infective eggs.
• Immunosuppression (e.g., HIV, corticosteroid therapy) – can worsen or prolong eosinophilic lung disease.
• Occupations with soil exposure (farmers, construction workers, gardeners).

Diagnosis

Diagnosis rests on a combination of clinical suspicion, laboratory findings, and imaging studies. The goal is to confirm eosinophilic lung involvement and identify the underlying cause.

History & Physical Examination

• Travel or exposure history to endemic regions.
• Recent ingestion of raw/undercooked foods or contact with contaminated soil.
• Physical exam may reveal wheezes, crackles, or mild tachypnea.

Laboratory Tests

• Complete blood count (CBC) with differential – peripheral eosinophilia (>500 cells/µL) is a hallmark.
• Serum IgE – often elevated, reflecting the allergic‑type response.
• Stool ova and parasite (O&P) examination – multiple samples increase detection sensitivity.
• Serologic tests – ELISA or immunoblot for specific helminth antibodies (e.g., Ascaris‑specific IgE).
• In atypical cases, a bronchoalveolar lavage (BAL) may be performed; BAL fluid typically shows >25 % eosinophils.

Imaging

• Chest X‑ray – “fleeting” peripheral infiltrates that appear in different lung zones over days; usually bilateral.
• High‑resolution CT (HRCT) – may reveal patchy ground‑glass opacities, nodular infiltrates, or interlobular septal thickening; helps exclude other interstitial lung diseases.

Differential Diagnosis

Conditions that can mimic Löffler syndrome include:

• Chronic eosinophilic pneumonia
• Allergic bronchopulmonary aspergillosis (ABPA)
• Hypersensitivity pneumonitis
• Drug‑induced eosinophilic lung disease
• Parasitic infections with extra‑pulmonary manifestations (e.g., schistosomiasis)

Accurate diagnosis often requires ruling out these alternatives through targeted history, labs, or biopsy.

Treatment Options

Because most cases are self‑limited, treatment primarily focuses on eradicating the causative parasite and alleviating symptoms.

Antiparasitic Medications

• Albendazole – 400 mg orally twice daily for 3 days (most common for Ascaris).
• Mebendazole – 100 mg orally twice daily for 3 days; alternatives where albendazole unavailable.
• Ivermectin – 200 µg/kg PO single dose for Strongyloides; may be repeated after 2 weeks.
• For filarial infections, diethylcarbamazine (DEC) or ivermectin‑based regimens are used per WHO guidelines.

All medications are safe in pregnancy (albendazole after the first trimester) and in children >2 years, but dosing should be individualized.

Corticosteroids

Short courses of oral prednisone (e.g., 0.5 mg/kg/day for 5–7 days) can dramatically reduce lung inflammation and cough in severe or prolonged cases. Steroids are *not* routinely required for mild disease.

Symptomatic Relief

• Bronchodilators (inhaled short‑acting β2‑agonists) for wheeze or dyspnea.
• Acetaminophen for fever or chest discomfort.
• Adequate hydration and rest.

Lifestyle & Supportive Measures

• Avoid smoking and second‑hand smoke, which can exacerbate airway inflammation.
• Maintain good nutrition to support immune recovery.
• Educate family members about hygiene to prevent reinfection.

Living with Löffler Syndrome

Most patients recover fully within weeks, but the following tips help manage any lingering symptoms and prevent recurrence.

Daily Management

• Track symptoms – keep a diary of cough, wheeze, or fever; note improvement after antiparasitic therapy.
• Pulmonary hygiene – practice deep‑breathing exercises (e.g., diaphragmatic breathing) twice daily to keep airways clear.
• Medication adherence – complete the full antiparasitic course even if you feel better.
• Follow‑up labs – repeat CBC 2–3 weeks post‑treatment to ensure eosinophil count returns to normal.
• School or work – most individuals can return to normal activities once fever resolves; inform teachers/employers about the transient nature of the condition.

Psychosocial Support

Because the term “eosinophilia” can sound alarming, reassure patients that Löffler syndrome is usually benign. Provide resources such as CDC parasite‑prevention pamphlets and community health worker contacts for families in endemic areas.

Prevention

Since the syndrome is almost always secondary to a parasitic infection, primary prevention focuses on interrupting the parasite life cycle.

• Hand hygiene – wash hands with soap and water after using the toilet and before handling food.
• Safe water – drink boiled or filtered water; avoid untreated surface water in endemic regions.
• Food safety – wash vegetables thoroughly; peel or cook root crops that may be contaminated.
• Foot protection – wear shoes when walking on soil or sand.
• Sanitation – use latrines or flush toilets; community deworming programs (annual albendazole 400 mg) have reduced prevalence by up to 70 % in school‑age children (WHO).
• Pet care – deworm pets regularly, as dogs and cats can harbor Toxocara spp.

Complications

Although rare, untreated or recurrent infection can lead to:

• Chronic eosinophilic pneumonia – persistent infiltrates causing fibrosis.
• Airway hyper‑reactivity – increased risk of asthma‑like symptoms.
• Systemic involvement – Ascaris larvae can migrate to the liver, pancreas, or heart (rare but serious).
• Severe Strongyloides infection – hyperinfection syndrome in immunocompromised persons, leading to sepsis.
• Growth retardation in children – due to chronic malnutrition from repeated helminth infections.

When to Seek Emergency Care

Key Takeaways

• Löffler syndrome is a short‑lived, eosinophil‑rich lung disease most often caused by migrating helminth larvae.
• Typical presentation includes a dry cough, fleeting pulmonary infiltrates on X‑ray, and peripheral eosinophilia.
• Diagnosis combines exposure history, blood tests, stool ova studies, and imaging.
• Standard treatment is a brief course of an anthelmintic (albendazole or ivermectin); steroids are reserved for severe inflammation.
• Prevention hinges on good hygiene, safe water, and community deworming programs.
• Most patients recover completely, but prompt treatment prevents rare complications.

For personalized advice, always consult a healthcare professional. References: Mayo Clinic, CDC, WHO, NIH National Library of Medicine, and peer‑reviewed articles from *The Lancet Infectious Diseases* and *Chest* journal (2022‑2024).

```